The Stroke Association is part of the Patient and Public Involvement Strategy, led by Dr Ava Easton on a grant worth £2.3 million to investigate the neurological and neuropsychiatric effects of COVID-19.
Disease of the chest portion of the largest artery in the body (the aorta), is known as thoracic aortic disease (TAD). The number of people experiencing TAD is increasing. This study is investigating how to make thoracic endovascular aortic stenting (TEVAR), the preferred method of treating TAD, safer by using extra protection devices.
Testing the idea that fatigue occurring after stroke is due to changes in the brain regions controlling the muscles using non-invasive brain stimulation and brain imaging techniques in 142 stroke patients, half of who will be those who complain of fatigue.
Your brain is amazing! It has the ability to re-wire itself, allowing you to improve skills such as walking, talking and using your affected arm. This process is known as neuroplasticity. Plasticity means your brain's ability to change. It begins after a stroke, and it can continue for years.
Stenting of the carotid arteries (running up the sides of the neck) is a common surgical procedure to reduce the risk of stroke. Stenting involves inserting a metal mesh into the artery to help widen it and improve blood flow. However, a new study published in the journal Neurology suggests that stenting of the vertebral arteries (that run up the neck behind the carotid arteries) appears safe too.
Published online (ahead of print in the journal Annals of Neurology), the results of a new study found that one year after arterial ischaemic stroke (AIS), the rate of death, recurrence of stroke, and neurological impairment was lower than reports in previous studies.
Promising research results for a new drug treatment for ischaemic stroke patients have been published today in the journal ‘Lancet Neurology’.